His primary areas of investigation include Genome-wide association study, Genetics, Single-nucleotide polymorphism, Internal medicine and Genetic association. Paul R. Burton has researched Genome-wide association study in several fields, including Blood pressure, COPD, Disease, Locus and Candidate gene. His Disease study incorporates themes from Coronary artery disease, Computational biology and Meta-analysis.
Paul R. Burton regularly ties together related areas like Cardiology in his Internal medicine studies. His work carried out in the field of Genetic association brings together such families of science as Odds ratio, Endocrinology, TCF7L2 and Diabetes mellitus genetics. The study incorporates disciplines such as SNP, Genetic predisposition, Human genetics and CDKN2BAS in addition to Allele frequency.
Paul R. Burton mainly focuses on Genetics, Internal medicine, Asthma, Pediatrics and Immunology. His is involved in several facets of Genetics study, as is seen by his studies on Single-nucleotide polymorphism, Genome-wide association study, Genetic association, Genetic linkage and Quantitative trait locus. His studies deal with areas such as Allele and Allele frequency as well as Single-nucleotide polymorphism.
His research integrates issues of Disease, Locus and Candidate gene in his study of Genome-wide association study. His study in Internal medicine is interdisciplinary in nature, drawing from both Anesthesia, Endocrinology and Cardiology. His study on Pediatrics also encompasses disciplines like
Paul R. Burton focuses on Internal medicine, Data sharing, Confidentiality, Cohort study and Atrial fibrillation. Paul R. Burton interconnects Endocrinology and Cardiology in the investigation of issues within Internal medicine. His Confidentiality research includes elements of Biobank and Open data.
He works mostly in the field of Cohort study, limiting it down to concerns involving Cohort and, occasionally, Epidemiology, Gerontology, Obesity, Industrial engineering and Sample size determination. His Epidemiology research includes themes of Meta-analysis, Large population, Global health and Blood pressure. His Atrial fibrillation study also includes
His primary areas of study are Confidentiality, Cohort, Genome-wide association study, Genetics and Asthma. His research in Cohort intersects with topics in Body mass index, Obesity, Gerontology and Cohort study. Paul R. Burton has included themes like Eosinophilia, Exacerbation, Disease, Severity of illness and Pediatrics in his Obesity study.
His study looks at the relationship between Cohort study and topics such as Type 2 diabetes, which overlap with Internal medicine. His Genome-wide association study research is multidisciplinary, relying on both Nephrology, Kidney disease, Renal function, Allele and Genetic variation. The Asthma study combines topics in areas such as Pulmonary disease, COPD and Eosinophilic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock.
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age
Cathie Sudlow;John Edward Gallacher;Naomi Allen;Valerie Beral.
PLOS Medicine (2015)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand.
The New England Journal of Medicine (2012)
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Georg B. Ehret;Georg B. Ehret;Georg B. Ehret;Patricia B. Munroe;Kenneth M. Rice;Murielle Bochud.
Genome-wide association study identifies eight loci associated with blood pressure
Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin.
Nature Genetics (2009)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock.
Nature Genetics (2007)
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C Michael Gibson;Roxana Mehran;Christoph Bode;Jonathan Halperin.
The New England Journal of Medicine (2016)
Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study
Nadia Badawi;Jennifer J Kurinczuk;John M Keogh;Louisa M Alessandri.
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson.
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
JL Mega;E Braunwald;S Mohanavelu;P Burton.
The Lancet (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: